Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_360a3ad4823e19184c65801aeff7ee97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-329 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-13039 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a0c51096356a89c19669535041b69d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbb0c3a3fe99d2c5bd8f449878006f13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_546c7d55251b4383a6a8c01d45eb5f65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5faff284a767a5cdfc31f528b9d8047 |
publicationDate |
2019-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3427061-A1 |
titleOfInvention |
In vitro method for identifying thoracic aortic aneurysms (taa) in a subject |
abstract |
The present invention refers to an In vitro method for screening for subjects at risk of developing thoracic aortic aneurysm (TAA) or a disease causing TAA comprising: (a) measuring the expression pattern or level of at least A Disintegrin And Metalloproteinase with Thrombospondin Motifs 1 (ADAMTS1) obtained from an isolated biological sample of the subjects to be screened; and (b) comparing said expression pattern or level of at least ADAMTS1 of the subjects to be screened with an already established expression pattern or level, wherein reduced expression of at least ADAMTS1 is indicative of a thoracic aortic aneurysm (TAA). |
priorityDate |
2016-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |